Ruiwen Zhang

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Molecular targeting therapies for neuroblastoma: Progress and challenges”.

Molecular targeting therapies for neuroblastoma: Progress and challenges

Medicinal Research Reviews(2020)10.1002/med.21750

N/A

0DataRank · unranked

395 citations

Wei Wang, Gang Liu, Xinjie Wang, Wa Xian, Frank McKeon +4 more

Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope

Cancer Letters(2020)10.1016/j.canlet.2020.09.023

N/A

0DataRank · unranked

115 citations

Wei Wang, Gang Liu, Wa Xian, Frank McKeon, Jia Zhou +2 more

Targeting MDM2 for Neuroblastoma Therapy: In Vitro and In Vivo Anticancer Activity and Mechanism of Action

Cancers(2020)10.3390/cancers12123651

N/A

0DataRank · unranked

15 citations

Xinjie Wang, Mehrdad Rajaei, Ji Youn Youn, Atif Zafar, Hemantkumar Deokar +6 more

Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action

Cells(2020)10.3390/cells9071592

N/A

0DataRank · unranked

20 citations

Viswanath Arutla, Wei Zhao, Mehrdad Rajaei, Hemantkumar Deokar, Ruiwen Zhang +4 more

Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer

European Journal of Medicinal Chemistry(2020)10.1016/j.ejmech.2020.112866

N/A

0DataRank · unranked

17 citations

Sadisna Shahi, Racheal G. Akwii, Md Sanaullah Sajib, Mohammad Jodeiri Farshbaf, Raja Reddy Kallem +8 more

Two Birds with One Stone: NFAT1-MDM2 Dual Inhibitors for Cancer Therapy

Cells(2020)10.3390/cells9051176

N/A

0DataRank · unranked

12 citations

Atif Zafar, Mehrdad Rajaei, Ruiwen Zhang, Wei Wang

Retracted: Structural studies of antitumor compounds that target the RING domain of MDM2

Protein Science(2022)10.1002/pro.4367

N/A

0DataRank · unranked

2 citations

Sijia Tang, Oluwafoyinsola Omobodunde Faniyi, In Ho Jeong, Jun Yin, Bhavitavya Nijampatnam +5 more

Targeting the MYCN-MDM2 pathways for cancer therapy: Are they druggable?

Genes & Diseases(2023)10.1016/j.gendis.2023.101156

N/A

0DataRank · unranked

7 citations

Yi Du, Sayantap Datta, Josef F. Fowler, Hannah T. Sang, Najah Albadari +4 more

MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future

Pharmacological Reviews(2024)10.1124/pharmrev.123.001026

N/A

0DataRank · unranked

127 citations

Najah Albadari, Yi Du, Josef F. Fowler, Hannah T. Sang, Wa Xian +5 more

Dual inhibitor of MDM2 and NFAT1 for experimental therapy of breast cancer: in vitro and in vivo anticancer activities and newly discovered effects on cancer metabolic pathways

Frontiers in Pharmacology(2025)10.3389/fphar.2025.1531667

N/A

0DataRank · unranked

1 citations

Marlene Aguilar, Sayantap Datta, Abigail Alley, Meheret Tadesse, Xinshi Wang +3 more

Targeting MDM2, RAS, and PCNA for cancer targeted therapy: pan-cancer approaches vs. cancer-specific strategies

Frontiers in Pharmacology(2025)10.3389/fphar.2025.1663766

N/A

0DataRank · unranked

0 citations

Abigail Alley, Na Sun, Meheret Tadesse, Xinshi Wang, Ruiwen Zhang +1 more